Abbott Laboratories buy Wells Fargo & Company
Start price
13.12.23
/
50%
€98.55
Target price
13.12.24
€112.13
Performance (%)
-0.73%
Price
29.07.24
€96.81
Summary
This prediction is currently active. The BUY prediction by Wells_Fargo___Compan for Abbott Laboratories is nearly unchanged. Dividends of €1.02 are taken into consideration when calculating the performance. This prediction currently runs until 13.12.24. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | 1.723% | 1.723% |
iShares Core DAX® | -0.598% | 0.645% |
iShares Nasdaq 100 | -3.290% | -4.193% |
iShares Nikkei 225® | -0.796% | -0.582% |
iShares S&P 500 | -1.164% | -0.857% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Wells Fargo & Company from $116.00 to $121.00. They now have an "overweight" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€88.90
19.10.23
19.10.23
€109.69
19.10.24
19.10.24
10.04%
29.07.24
29.07.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€93.86
05.04.23
05.04.23
€124.25
05.04.24
05.04.24
8.89%
06.04.24
06.04.24